Inventor
Linda P. Dwoskin
Inventor
Lexington, KY, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
10,668,030Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse202010,071,982Method of treating neuropathic pain20189,649,301'Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors'20179,550,753'Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors'20179,540,327'Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors'20179,499,518'Bis-quaternary ammonium salts as pain modulating agents'20169,155,733'Use of tris-quaternary ammonium salts as pain modulating agents'20158,940,774'Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors'20158,846,937'Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors'20148,703,803'Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors'20148,653,275'Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors'20148,629,163'Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors'20148,546,415'Bis-pyridino containing compounds for the use in the treatment of CNS pathologies'20138,299,253'Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors'20128,178,678'Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors'20127,368,443'2,6-disubstituted piperidines and piperazine compounds'20086,943,177'Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies'20056,703,406'2,6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storage'20046,503,922'Bridged nicotine compounds for use in the treatment of CNS pathologies'20036,455,543'Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies'20026,087,376'Use of lobeline compounds in the treatment of central nervous system diseases and pathologies'20005,830,904'Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders'19985,776,957'Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states'19985,691,365'Nicotinic receptor antagonists in the treatment of neuropharmacological disorders'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2020Patents assigned to UNIV KENTUCKY RES FOUND (24)· patent assignee history
1997–2020Based in Lexington, KY, US· patent location history
2012–2017Patents assigned to DWOSKIN LINDA P (8)· patent assignee history
2012–2017Patents assigned to CROOKS PETER (5)· patent assignee history
2012–2017Patents assigned to SUMITHRAN SANGEETHA (5)· patent assignee history
2012–2017Patents assigned to ZHENG GUANGRONG (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV KENTUCKY RES FOUND | 24 | 1997–2020 |
| DWOSKIN LINDA Pself | 8 | 2012–2017 |
| CROOKS PETER | 5 | 2012–2017 |
| SUMITHRAN SANGEETHA | 5 | 2012–2017 |
| ZHENG GUANGRONG | 5 | 2012–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lexington, KY, US | 24 | 1997–2020 |